puc-header

Multiomics Personalized Network Analyses Highlight Progressive Immune Disruption of Central Metabolism Associated with COVID-19 Severity

54 Pages Posted: 17 Dec 2021 Publication Status: Published

See all articles by Anoop T. Ambikan

Anoop T. Ambikan

Karolinska Institutet - Division of Clinical Microbiology

Hong Yang

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab)

Shuba Krishnan

Karolinska Institutet - Division of Clinical Microbiology

Sara Svensson-Akusjärvi

Karolinska Institutet - Division of Clinical Microbiology

Soham Gupta

Karolinska Institutet - Division of Clinical Microbiology

Magda Lourda

Karolinska Institutet

Maike Sperk

Karolinska Institutet

Muhammad Arif

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab)

Cheng Zhang

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab)

Hampus Nordqvist

Region Stockholm

Sivasankaran Munusamy Ponnan

Indian Institute of Science (IISc) - Centre for Infectious Disease Research

Anders Sönnerborg

Karolinska Institutet - Division of Clinical Microbiology

Carl Johan Treutiger

Södersjukhuset (Sös) - Department of Infectious Diseases

Liam O’Mahony

University College Cork - School of MicroBiology

Adil Mardinoglu

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab)

Rui Benfeitas

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab)

Ujjwal Neogi

Karolinska Institutet - The Systems Virology Lab; Karolinska Institutet - Division of Clinical Microbiology

More...

Abstract

The system-wide metabolomics profile in COVID-19 patients identified several biomarkers that shed mechanistic insights into how SARS-CoV-2 infection is associated with gender, age, ethnicity, and co-morbidities. However, the clinical outcome and disease severity are heterogenous and cannot explain by a single factor. In this study, we used system-wide network-based system biology analysis using whole blood RNA-seq, immune-phenotyping by flow cytometry, plasma metabolomics, and single cell-type metabolomics to identify the metabo-transcriptomics mechanism of COVID-19 severity at the personalized and group level. Digital cell quantification and immune-phenotyping of the mononuclear phagocytes (MNPs) indicated a substantial role in coordinating the immune cells that mediate the COVID-19 disease severity. Stratum-specific and personalized genome-scale metabolic modeling indicated that transporter genes such as SLC16A6 and SLC29A1, and metabolites such as α-ketoglutarate, succinate, malate, and butyrate, could play a crucial role in COVID-19 severity can be the potential targetable elements for COVID-19 treatment depending on disease severity.

Funding: The study is funded by the Swedish Research Council grants 2021-00993 (UN), 2017-01330 (UN), 2018-06156 (UN), and 2021-03035 (SG) and support received from Karolinska Institutet Stiftelser och Fonder grant 2020-01554 (UN) and 2020-02153 (SG), The Center for Medical Innovation grant CIMED-FoUI-093304 (SG) and Åke Wiberg Stiftelse grant M20-0220 (SG).

Declaration of Interests: Authors declare that they have no competing interests.

Ethics Approval Statement: The study was approved by the regional Ethics Committee in Stockholm, Sweden, and performed in accordance with the Declaration of Helsinki.

Keywords: COVID-19, Similarity Network Fusion, personalised genome scale metabolic model

Suggested Citation

Ambikan, Anoop T. and Yang, Hong and Krishnan, Shuba and Svensson-Akusjärvi, Sara and Gupta, Soham and Lourda, Magda and Sperk, Maike and Arif, Muhammad and Zhang, Cheng and Nordqvist, Hampus and Ponnan, Sivasankaran Munusamy and Sönnerborg, Anders and Treutiger, Carl Johan and O’Mahony, Liam and Mardinoglu, Adil and Benfeitas, Rui and Neogi, Ujjwal, Multiomics Personalized Network Analyses Highlight Progressive Immune Disruption of Central Metabolism Associated with COVID-19 Severity. Available at SSRN: https://ssrn.com/abstract=3988390 or http://dx.doi.org/10.2139/ssrn.3988390
This version of the paper has not been formally peer reviewed.

Anoop T. Ambikan

Karolinska Institutet - Division of Clinical Microbiology ( email )

Sweden

Hong Yang

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab) ( email )

Lindstedtsvägen 30-100 44
Stockholm, SE-100 44
Sweden

Shuba Krishnan

Karolinska Institutet - Division of Clinical Microbiology ( email )

Sweden

Sara Svensson-Akusjärvi

Karolinska Institutet - Division of Clinical Microbiology ( email )

Sweden

Soham Gupta

Karolinska Institutet - Division of Clinical Microbiology ( email )

Sweden

Magda Lourda

Karolinska Institutet ( email )

Granits väg 4
Section for Integrative Physiology
Solna, 17171
Sweden

Maike Sperk

Karolinska Institutet ( email )

Granits väg 4
Section for Integrative Physiology
Solna, 17171
Sweden

Muhammad Arif

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab) ( email )

Lindstedtsvägen 30-100 44
Stockholm, SE-100 44
Sweden

Cheng Zhang

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab) ( email )

Lindstedtsvägen 30-100 44
Stockholm, SE-100 44
Sweden

Hampus Nordqvist

Region Stockholm ( email )

Stockholm
Sweden

Sivasankaran Munusamy Ponnan

Indian Institute of Science (IISc) - Centre for Infectious Disease Research ( email )

Bangalore, IN Karnataka 560012
India

Anders Sönnerborg

Karolinska Institutet - Division of Clinical Microbiology ( email )

Sweden

Carl Johan Treutiger

Södersjukhuset (Sös) - Department of Infectious Diseases ( email )

Liam O’Mahony

University College Cork - School of MicroBiology ( email )

Ireland

Adil Mardinoglu

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab) ( email )

Lindstedtsvägen 30-100 44
Stockholm, SE-100 44
Sweden

Rui Benfeitas

Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab) ( email )

Lindstedtsvägen 30-100 44
Stockholm, SE-100 44
Sweden

Ujjwal Neogi (Contact Author)

Karolinska Institutet - The Systems Virology Lab ( email )

Karolinska Institutet - Division of Clinical Microbiology ( email )

Sweden

Click here to go to Cell.com

Paper statistics

Downloads
48
Abstract Views
846
PlumX Metrics